[1]
Lieberman, J.A.; Michael, B.F. Psychotic Disorders. New Eng-land. J. Med., 2018, 379, 270-280.
[8]
Sovner, R.; Dimascio, A.; Killam, F. Extrapyrmidal syn-dromes and the other neurological side effects of psycho-tropic drugs. Psychopharmacology: A Generation of Pro-gress; Lipton, M.A.; DiMascio, A. Killam, F., Eds. Raven Press. New York, 1978, pp. 1021-1032.
[36]
Gottesman, I.I. Schizophrenia genesis: The origins of mad-ness; W.H. & Freeman Company: New York, 1991.
[44]
Kumar, P.N.S.; Anish, P.K.; Rajmohan, V. Olanzapine has better efficacy compared to risperidone for treatment of nega-tive symptoms in schizophrenia. Int. J. Psychiatry, 2016, 58(3), 311-316.
[47]
Komossa, K.; Rummel-Kluge, C.; Schmid, F.; Hunger, H.; Schwarz, S.; El-Sayeh, H.G.G.; Kissling, W.; Leucht, S. Aripiprazole versus other atypical antipsychotics for schizo-phrenia Cochrane Database Sys. Rev., 2009, 4
[55]
Michele, F.; Domenico, D.B.; Giampaolo, P.; Marco, S.; Nico-la, V.; Laura, O.; Elisabetta, F.B.; Felice, I.; Cristiano, A.K.; Andre, F.C.; Andrea, D.B. Lurasidone in the treatment of bipolar depression: systematic review of systematic reviews Hindawi BioMed. Res. Int., 2017.
[63]
Kebamo, S.; Tesema, S.; Geleta, B. The role of biotransformation in drug discovery and development. Drug Metab. Tox-icol., 2015, 6, 1-13.
[75]
Van de W.K.S.F.; Jacobs, P.L; Kemperman, G.J.; Spaans, E.; Peeters, P.A.; Delbressine, L.P.; Van, I.M.L. Metabolism and excretion of asenapine in healthy male subjects. Drug Metab. Dispos., 2011, 39, 580-590.
[89]
Gandhimathi, R.; Vijayaraj, S.; Jyothirmaie, M.P. Method development and validation of uvspectroscopic method for estimation of asenapine maleate in bulk and tablet formulation. Int. J. Med. Chem. Anal., 2012, 2, 85-90.
[123]
El-Didamony, A.M.; Hafeez, S.M.; Hafez, M.M.A. Spectro-photometric determination of aripiprazole, clozapine ans sul-piride by ion pair extraction in tablets and biological fluids. Int. J. Pharm. Pharm. Sci., 2015, 7, 178-184.
[124]
El-Didamony, A.M.; Hafeez, S.M.; Ali, I.I. Spectrophotomet-ric determination of four selected antipsychotic drugs in dos-age forms and biological fluids. Int. J. Pharm. Sci. Rev. Res., 2014, 28, 52-60.
[125]
Basavaiah, K.; Tharpa, K.; Nagaraju, R.; Hiriyanna, S.G.; Vinaya, K.B. Spectrophotometric determination of antipsy-chotic drug olanzapine in pharmaceuticals. Jordan J. Chem., 2009, 4, 65-76.
[126]
Basavaiah, K.; Abdulrahman, S.A.M.; Vinay, K.B. Simple and Sensitive Spectrophotometric Determination of olanzapine in pharmaceutical formulations using two sulphonphthalein acid dyes. Yao Wu Shi Pin Fen Xi, 2009, 17, 434-442.
[129]
Ali, A.A.A.; Elbashir, A.A. Optimized and validated spectro-photometric method for the determination of olanzapine in pharmaceutical formulations using 1,2,-Naphthoquinone-4-Sulphonate (NQS). Am. Acad. Schol. Res. J., 2012, 4, 51-66.
[132]
Rajendraprasad, N.; Basavaiah, K.; Tharpa, K.; Vinay, K.B. Quantitative determination of olanzapine in tablets with visi-ble spectrophotometry using cerium(iv) sulphate and based on redox and complexation reactions. Eur. J. Anal. Chem., 2009, 4, 191-203.
[134]
Basavaiah, K.; Abdulrahman, S.A.M. Utility of n-bromosuccinimide as an environmental-friendly reagent for sensitive determination of olanzapine in pharmaceuticals. Jordan J. Pharm. Sci., 2011, 4, 209-221.
[137]
Basavaiah, K.; Abdulrahman, S.A.M. Sensitive and selective methods for the determination of olanzapine in pharmaceuti-cals using n-bromosuccinimide and two dyes. Int. J. Chemtech Res., 2010, 2, 660-668.
[138]
Vivek, M.P.; Jigar, A.P.; Shweta, S.H.; Sunil, R. First and Sec-ond derivative spectrophotometric methods for determination of olanzapine in pharmaceutical formulation. Int. J. Chemtech Res., 2010, 2, 756-761.
[139]
Firdous, S.; Aman, T.; Nisa, A.U. Determination of olanzap-ine by UV spectrophotometry and non-aqueous titration. J. Chem. Soc. Pak., 2005, 27, 163-167.
[140]
Kumar, S.R.; Gayathri, P.; Duganath, N.; Kiran, C.H.; Sridhar, C.; Jayaveera, K.N. Simultaneous estimation of fluoxetine hcl and olanzapine in bulk drug and pharmaceutical formulation by using uv-visible spectroscopy method. Int. J. Pharm. Sci. Drug Res., 2011, 3, 52-55.
[142]
Sahar, R.F.; Najwa, I.A.; Intidhar, D.S. The spectrophotomet-ric determination of olanzapine via coupling with diazotized p-nitroaniline. Iraqi J. Pharm Sci., 2016, 25, 42-49.
[144]
Dey, S.; Chauhan, N.; Malairajan, P.; Murugan, R.; Das, R.C.; Ahmad, S. A simple and rapid spectrophotometric determina-tion of aripiprazole in pharmaceutical dosage form. Int. J. Drug Dev. Res., 2011, 3, 205-208.
[146]
Nagamallika, J.; Aruna, M. Development and validation of spectrophotometric method for the estimation of aripiprazole in tablet dosage form. Asian J. Pharm. Anal., 2011, 3, 46-49.
[149]
Subbayamma, A.V.; Rambabu, C. Spectrophotometric deter-mination of aripiprazole in pharmaceutical formulation with MBTH and ferric chloride. Orient. J. Chem., 2008, 24, 677-680.
[150]
Helmy, A.G.; Abdel-Gawad, F.M.; Mohamed, E.F. Spectropho-tometric study on determination of aripiprazole in tablets by charge transfer and ion pair complexation reaction with some acceptors. Asian J. Pharm. Anal., 2012, 2, 12-19.
[151]
Ramya, N.S.; Vijayalakshmi, R.; Dhanaraju, M.D. Spectro-photometric determination of aripiprazole and tapentadol us-ing chloranillic acid reagent. Int. J. Pharm. Sci. Res., 2015, 6, 2052-2055.
[152]
Bagade, S.B.; Narkhede, S.P.; Nikam, D.S.; Sachde, C.K. Devel-opment and validation of UV-spectrophotometric method for determination of quetiapine fumarate in two different dose tablets. Int. J. Chemtech Res., 2009, 1, 898-904.
[153]
Valarmathi, R.; Dhharshini, C.S.D.; Senthamarai, R.; Banu, S.F. Analytical method development of quetiapine fumerate in bulk and its tablet formulation by simple UV spectropho-tometry. Int. J. Drug Dev. Res., 2013, 5, 366-372.
[154]
Vinay, K.B.; Revanasiddappa, H.D. Spectrophotometric de-termination of quetiapine fumarate through ion-pair complex-ation reaction with tropaeolin ooo. Indian J. Chem. Technol., 2012, 19, 205-212.
[157]
Mostafa, I.M.; Omar, M.A.; Nagy, D.M.; Derayea, S.M. Anal-ysis of quetiapine in human plasma using fluorescence spec-troscopy. Spectropchim. Acta Part A: Molecul. Biomol. Spec-tros., 2018, 196, 196-201.
[158]
El-Enany, N.; Belal, F.; El-Brashy, A.; El-Bahy, N. Spectro-fluorimetric determination of flupentixol dihydrochloride and quetiapine in pharmaceutical preparations and spiked human plasma via oxidation with cerium (IV). Anal. Chem. Indian J., 2009, 8, 325-333.
[166]
Kaewvichit, S.; Sangsrijan, S.; Sangsrijan, S. Determination of clozapine in human plasma by high performance liquid chro-matography with UV-VIS detector. CMU. J. Nat. Sci., 2010, 9, 29-37.
[169]
Tyagi, M.G. Estimation of clozapine in human plasma by high performance liquid chromatography and detection by UV-VIS detector. Asian J. Biochem. Pharm. Res., 2012, 2, 49-53.
[170]
Patil, U.A.; Ghosh, B. Reverse phase liquid chromatographic method for the estimation of clozapine from tablet dosage forms. Int. J. Pharm. Tech. Res., 2009, 1, 733-736.
[172]
Basavaiah, K.; Rajendraprasad, N.; Vinay, K.B. Isocratic high-performance liquid chromatographic assay of olanzapine. Method development and validation ISRN. Anal. Chem., 2014, 1-6.
[182]
Nandini, R.; Dubhashi, S.D. Development of stability indicating validated HPLC method for quantitative determination of ari-piprazole and its impurities. Der Pharm. Lett., 2010, 2, 1-10.
[183]
Soponar, F.; Sandru, M.; David, V. Quantitative evaluation of aripiprazole and its five related chemical impurities from pharmaceuticals using HPLC-DAD method. Rev. Roum. Chim., 2014, 59, 1037-1046.
[186]
Vijaya, K.M.; Muley, P.R. Determination of aripiprazole in bulk drug and solid dosage forms by RP-HPLC meth-od. Indian Pharm., 2005, 4, 71-75.
[190]
Bhanotu, B.; Srinath, P.; Kedarnath, J. Development, estima-tion and validation of aripiprazole in bulk and its pharmaceu-tical formulation by HPLC method. Int. J. Chemtech Res., 2012, 4, 124-128.
[191]
Sastry, B.S.; Gananadhamu, S.; Rao, G.D. RP-HPLC determi-nation of aripiprazole in pharmaceutical formulations. Asian J. Chem., 2009, 21, 6643-6646.
[192]
Mondal, P.; Rani, S.S.; Alekhya, K. A new stability indicating validated method for the determination of aripiprazole in bulk and tablet dosage form using RP- HPLC. Int. J. Pharm. Pharma. Sci., 2013, 5(Suppl. 4), 660-665.
[194]
Dedania, Z.; Dedania, R.; Sheth, N.; Gajra, B.; Patel, J. Devel-opment and validation of a stability-indicating high perfor-mance liquid chromatography assay for aripiprazole in bulk drug substance. Asian J. Pharm. Biol. Res., 2011, 1, 123-128.
[195]
Pai, N.R.; Pusalkar, D.A. Development and validation of liq-uid chromatographic method for aripiprazole. Pharm. Sin., 2012, 3(5), 526-535.
[196]
Ravindra, N.; Singhvi, I.; Swamy, G.K. New RP-HPLC method for estimation of aripiprazole in bulk and in pharmaceutical dosage froms. Indo American J. Pharm. Res., 2014, 4, 1842-1849.
[197]
Kumari, M.V.; Eswaramma, P.; Kumar, A.E.S.; Rao, K.V.; Babu, M.N.; Begam, S.K.S. Analytical method validation of aripiprazole in pharmaceutical dosage form by RP-HPLC. World J. Pharm. Pharm. Sci., 2016, 5, 1168-1179.
[198]
Prashanthi, K.; Sravani, V.N.; Suganda, G.; Mothiram, M.; Spandana, B.; Mohan, C.H.K. Development of validated RP-HPLC method for quantitative determination of aripiprazole. Int. J. Pharm. Pharma. Res., 2016, 4, 313-321.
[200]
Nagasarapu, M.R.; Dannana, G. New stability indicating high performance liquid chromatography method for the estimation of aripiprazole in bulk and their formulations. Indian J. Drugs, 2017, 5(3), 116-123.
[206]
Zaheer, Z.; Farooqui, M.; Dhaneshwar, S.R. Stability-indicating high performance thin layer chromatographic de-termination of clozapine in tablet dosage form. J. Pharm. Sci. Res., 2009, 1, 158-166.
[207]
Younes, K.M. Stability indicationg spectrophotometric and TLC desitometric methods for the determination of ari-piprazole in bulk and dosage forms. Int. J. Pharm. Pharm. Sci., 2014, 9, 542-548.
[210]
Punugoti, R.A.; Jupally, V.R. Development and validation of new RP-UPLC method for the quantitative determination of olanzapine in tablet dosage form. Asian J. Pharm. Clin. Res., 2013, 6(Suppl. 3), 178-181.
[211]
Khandelwal, N.; Bharti, T.; Rajput, C.S.; Rathore, R.P.S. Ana-lytical method development and validation of olanzapine in formulated product. World J. Pharma. Res., 2015, 4, 1690-1699.
[220]
Wang, Y.; Wang, J.; Xia, X.; Wang, R.; Chen, S.; Wang, Z.; Qui, X. Quantitative determination of clozapine in rat plasma by liquid chromatography mass spectrometry and its application. Lat. Am. J. Pharm., 2013, 32, 668-673.
[229]
Skibinski, R. A study of photodegradation of quetiapine by the use of LC-MS/MS method. Cent. Eur. J. Chem., 2012, 10, 232-240.
[232]
Demacker, P.N.M.; Beijers, A.M.; Daal, V.H. Van den O.J.M.W. Assay of eight tricyclic antidepressants and nor clozapine by UPLC-MS/MS. Ned. Tijdschr. Klin. Chem. Labgeneesk, 2009, 34(4), 224-225.
[239]
Al-Bukhaiti, W.Q.; Noman, A.; Qasim, A.S.; Al-Farga, A. Gas chromatography: principles, advantages and applications in food analysis. Int. J. Agric. Innov. Res., 2017, 6, 123-128.
[247]
Zhou, D.W.; Li, F.M. Determination of free clozapine concen-tration in serum and plasma by capillary electrophoresis-frontal analysis. Acta Chimi. Sin., 2004, 62(13), 1256-1259.
[250]
Qin, H.; Song-jiu, T.; Bao-quan, C.; Liang, Z. Analysis of five antipsychotic drugs by capillary zone electrophoresis. Yaowu Fenxi Zazhi, 2001, 21, 412-414.
[253]
Manjunatha, J.G.; Swamy, B.E.K.; Mamatha, G.P.; Gilbert, O.; Srinivas, M.T.; Sherigara, B.S. Electrochemical studies of clozapine drug using carbon nanotubes-SDS modified carbon paste electrode: a cyclic voltammetry study. Pharma Chem., 2011, 3(2), 236-249.